Invention Grant
US07638277B2 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
有权
卵巢癌中过表达的跨膜丝氨酸蛋白酶及其用途
- Patent Title: Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
- Patent Title (中): 卵巢癌中过表达的跨膜丝氨酸蛋白酶及其用途
-
Application No.: US11400825Application Date: 2006-04-07
-
Publication No.: US07638277B2Publication Date: 2009-12-29
- Inventor: Timothy J. O'Brien , Lowell J. Underwood
- Applicant: Timothy J. O'Brien , Lowell J. Underwood
- Applicant Address: US AR Little Rock
- Assignee: The University of Arkansas for Medical Sciences
- Current Assignee: The University of Arkansas for Medical Sciences
- Current Assignee Address: US AR Little Rock
- Agent Benjamin Aaron Adler
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The present invention provides a TADG-12 protein and a DNA fragment encoding such protein. Also provided is a vector/host cell capable of expressing the DNA. The present invention further provides various methods of early detection of associated ovarian and other malignancies, and of interactive therapies for cancer treatment by utilizing the DNA and/or protein disclosed herein.
Public/Granted literature
- US20060177866A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof Public/Granted day:2006-08-10
Information query
